Having trouble viewing this email? View it as a Web page.

HHSC to Participate in Cell and Gene Therapy Access Model, Beginning Sept. 1, 2025

Beginning Sept. 1, 2025, Texas Medicaid will participate in the Cell and Gene Therapy (CGT) Access Model.

Other News

• Change in PDL Status for Stimulants and Related Agents Drug Class, Effective Aug. 18, 2025
• Change in PDL Status for Stimulants and Related Agents Drug Class, Effective Aug. 11, 2025
• Temporary Non-preferred Drug Status to Start Sept. 1, 2025
• Labor Day Holiday to Delay Pharmacy Payments (Sept. 1)

Outreach and Training

• Reminder: Pharmacies Must Ensure Contact Information Is Current in PEMS
• VDP Provider Portal Registration, Training Information
  • For pharmacies
  • For prescribers
• Texas Health Steps Includes Pharmacy Education Opportunities